Dion R. Brocks

5.6k total citations
139 papers, 4.3k citations indexed

About

Dion R. Brocks is a scholar working on Pharmacology, Pharmacology and Oncology. According to data from OpenAlex, Dion R. Brocks has authored 139 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pharmacology, 45 papers in Pharmacology and 35 papers in Oncology. Recurrent topics in Dion R. Brocks's work include Pharmacogenetics and Drug Metabolism (53 papers), Drug Transport and Resistance Mechanisms (34 papers) and Analytical Methods in Pharmaceuticals (28 papers). Dion R. Brocks is often cited by papers focused on Pharmacogenetics and Drug Metabolism (53 papers), Drug Transport and Resistance Mechanisms (34 papers) and Analytical Methods in Pharmaceuticals (28 papers). Dion R. Brocks collaborates with scholars based in Canada, United States and Egypt. Dion R. Brocks's co-authors include Anooshirvan Shayeganpour, Reza Mehvar, Fakhreddin Jamali, Afsaneh Lavasanifar, Raj Padwal, Ayman O.S. El‐Kadi, Hamidreza Montazeri Aliabadi, Arya M. Sharma, Kishor M. Wasan and Raniah Q. Gabr and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biomaterials.

In The Last Decade

Dion R. Brocks

138 papers receiving 4.2k citations

Peers

Countries citing papers authored by Dion R. Brocks

Since Specialization

Citations

This map shows the geographic impact of Dion R. Brocks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dion R. Brocks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dion R. Brocks more than expected).

Fields of papers citing papers by Dion R. Brocks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dion R. Brocks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dion R. Brocks. The network helps show where Dion R. Brocks may publish in the future.

Co-authorship network of co-authors of Dion R. Brocks

This figure shows the co-authorship network connecting the top 25 collaborators of Dion R. Brocks. A scholar is included among the top collaborators of Dion R. Brocks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dion R. Brocks. Dion R. Brocks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	16R-HETE and 16S-HETE alter human cytochrome P450 1B1 enzyme activity probably through an allosteric mechanism 2023 ·Molecular and Cellular Biochemistry ·Rahmat Hidayat, Sherif M. Shoieb, (unknown), Khaled Barakat, Dion R. Brocks, (unknown), (unknown), Ayman O.S. El‐Kadi	7
2	Liquid Chromatography Tandem Mass Spectrometric Analytical Method for Study of Colchicine in Rats Given Low Doses 2021 ·Processes ·(unknown), (unknown), Neal M. Davies, Dion R. Brocks	6
3	Does a sudden shift of testing format from closed-book to open-book change the characteristics of test scores on summative final exams? 2021 ·Currents in Pharmacy Teaching and Learning ·(unknown), Dion R. Brocks	5
4	Dietary-Induced Obesity, Hepatic Cytochrome P450, and Lidocaine Metabolism: Comparative Effects of High-Fat Diets in Mice and Rats and Reversibility of Effects With Normalization of Diet 2019 ·Journal of Pharmaceutical Sciences ·(unknown), Rami Al Batran, John R. Ussher, Zaid H. Maayah, Ayman O.S. El‐Kadi, Dion R. Brocks	16
5	The Single Dose Poloxamer 407 Model of Hyperlipidemia; Systemic Effects on Lipids Assessed Using Pharmacokinetic Methods, and its Effects on Adipokines 2013 ·Journal of Pharmacy & Pharmaceutical Sciences ·(unknown), Dion R. Brocks	48
6	The ability of polycyclic aromatic hydrocarbons to alter physiological factors underlying drug disposition 2011 ·Drug Metabolism Reviews ·Marwa E. Elsherbiny, Dion R. Brocks	14
7	Variations in tissue selectivity amongst insulin secretagogues: a systematic review 2011 ·Diabetes Obesity and Metabolism ·Ahmed S. Abdel‐Moneim, (unknown), John M. Seubert, Dion R. Brocks, Peter E. Light, Scot H. Simpson	77
8	Effect of experimental hyperlipidaemia on the electrocardiographic effects of repeated doses of halofantrine in rats 2010 ·British Journal of Pharmacology ·(unknown), Dion R. Brocks	10
9	Multiple Peaking Phenomena in Pharmacokinetic Disposition 2010 ·Clinical Pharmacokinetics ·Neal M. Davies, Jody K. Takemoto, Dion R. Brocks, Jaime A. Yáñez	131
10	An analytical method for cyclosporine using liquid chromatography–mass spectrometry 2009 ·Biomedical Chromatography ·(unknown), (unknown), Afsaneh Lavasanifar, Dion R. Brocks	12
11	A stereospecific high‐performance liquid chromatographic assay for the determination of ketoconazole enantiomers in rat plasma 2008 ·Biomedical Chromatography ·Dalia A. Hamdy, Dion R. Brocks	26
12	Effects of intestinal constituents and lipids on intestinal formation and pharmacokinetics of desethylamiodarone formed from amiodarone 2008 ·Journal of Pharmacy and Pharmacology ·Anooshirvan Shayeganpour, Dalia A. Hamdy, Dion R. Brocks	4
13	Induction of Cytochrome P450 1A1 by Ketoconazole and Itraconazole but not Fluconazole in Murine and Human Hepatoma Cell Lines 2007 ·Toxicological Sciences ·Hesham M. Korashy, Anooshirvan Shayeganpour, Dion R. Brocks, Ayman O.S. El‐Kadi	49
14	A liquid chromatography–mass spectrometry assay method for simultaneous determination of amiodarone and desethylamiodarone in rat specimens 2007 ·Biomedical Chromatography ·Anooshirvan Shayeganpour, (unknown), Dion R. Brocks	17
15	Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat‐meal rat models 2005 ·Biopharmaceutics & Drug Disposition ·Anooshirvan Shayeganpour, (unknown), Dion R. Brocks	75
16	Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution 2005 ·Biomaterials ·Hamidreza Montazeri Aliabadi, Dion R. Brocks, Afsaneh Lavasanifar	109
17	The Influence of Lipids on Stereoselective Pharmacokinetics of Halofantrine: Important Implications in Food‐Effect Studies Involving Drugs That Bind to Lipoproteins 2002 ·Journal of Pharmaceutical Sciences ·Dion R. Brocks, Kishor M. Wasan	44
18	High-performance liquid chromatographic assay of (±)-ethopropazine and its enantiomers in rat plasma 1998 ·Journal of Chromatography B Biomedical Sciences and Applications ·(unknown), Dion R. Brocks	3
19	The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers 1996 ·European Journal of Clinical Pharmacology ·Dion R. Brocks, (unknown), Panayiotis Georgiou, (unknown), E. Doyle, Elisa Allen, P.J. Wyld, Michael J. Dennis	29
20	Etodolac Clinical Pharmacokinetics 1994 ·Clinical Pharmacokinetics ·Dion R. Brocks, Fakhreddin Jamali	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact